Published in Virology on December 01, 1972
Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J Virol (1973) 5.64
Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol (1983) 4.05
Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol (1973) 3.49
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol (1993) 2.94
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res (1985) 2.37
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun (1975) 2.01
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol (1995) 1.89
Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J Virol (1985) 1.87
Formation of protein micelles from amphiphilic membrane proteins. Proc Natl Acad Sci U S A (1978) 1.80
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol (1975) 1.77
Conformation of the helical nucleocapsids of paramyxoviruses and vesicular stomatitis virus: reversible coiling and uncoiling induced by changes in salt concentration. Proc Natl Acad Sci U S A (1980) 1.76
Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit. Nucleic Acids Res (1985) 1.69
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J Virol (1989) 1.68
Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. J Virol (1987) 1.67
Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol (1988) 1.67
The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol (1988) 1.60
Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J Virol (1993) 1.56
Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J Virol (1985) 1.53
Glycoproteins of measles virus under reducing and nonreducing conditions. J Virol (1978) 1.51
Proteolytic cleavage of subunits of the nucleocapsid of the paramyxovirus simian virus 5. J Virol (1974) 1.49
Receptor specificities of human respiroviruses. J Virol (2001) 1.48
Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3. J Virol (1984) 1.46
Sendai virion transcriptase complex: polyeptide composition and inhibition by virion envelope proteins. J Virol (1974) 1.45
Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J Cell Biol (1996) 1.44
Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein. J Virol (1986) 1.42
Isolation and characterization of Sendai virus temperature-sensitive mutants. J Virol (1974) 1.38
Analysis of Sendai virus mRNAs with cDNA clones of viral genes and sequences of biologically important regions of the fusion protein. Proc Natl Acad Sci U S A (1984) 1.30
Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity. J Virol (1987) 1.26
An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. Proc Natl Acad Sci U S A (1985) 1.26
Glycoproteins of Sendai virus are transmembrane proteins. Proc Natl Acad Sci U S A (1979) 1.22
Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J (2006) 1.21
Sulfated components of enveloped viruses. J Virol (1975) 1.21
Cell-free translation of paramyxovirus messenger RNA. J Virol (1973) 1.19
Synthesis, stability, and cleavage of Newcastle disease virus glycoproteins in the absence of glycosylation. J Virol (1980) 1.15
Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J Virol (1990) 1.11
Electron cryomicroscopy reveals different F1+F2 protein States in intact parainfluenza virions. J Virol (2008) 1.10
Polypeptides of mumps virus. J Virol (1976) 1.09
Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. J Virol (1989) 1.06
Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection. J Virol (2008) 1.06
Isolation and characterization of Clostridium perfringens mutants altered in both hemagglutinin and sialidase production. J Bacteriol (1975) 1.06
Proteins associated with human parainfluenza virus type 3. J Virol (1985) 1.04
Implantation of the isolated human erythrocyte anion channel into plasma membranes of Friend erythroleukemic cells by use of Sendai virus envelopes. Proc Natl Acad Sci U S A (1979) 1.02
Relationship between hemagglutinin and sialidase from Clostridium perfringens CN3870: chromatographic characterization of the biologically active proteins. J Bacteriol (1976) 1.02
Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus. Virology (2011) 1.01
Structure and assembly of a paramyxovirus matrix protein. Proc Natl Acad Sci U S A (2012) 1.01
The 3D structure of the fusion primed Sendai F-protein determined by electron cryomicroscopy. EMBO J (2003) 0.97
Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics. J Virol (1996) 0.95
Fatty acid modification of Newcastle disease virus glycoproteins. J Virol (1982) 0.94
Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus. J Virol (1989) 0.92
Sendai virus-induced hemolysis: reduction in heterogeneity of erythrocyte lipid bilayer fluidity. Proc Natl Acad Sci U S A (1977) 0.91
Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity. Thorax (1998) 0.91
Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins. Infect Immun (1980) 0.90
Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations. Infect Immun (1979) 0.85
Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection. J Virol (1988) 0.85
Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response. J Virol (1988) 0.84
Crystallization of biologically active hemagglutinin-neuraminidase glycoprotein dimers proteolytically cleaved from human parainfluenza virus type 1. J Virol (1992) 0.84
Molecular characterization of three new virulent Newcastle disease virus variants isolated in China. J Clin Microbiol (2007) 0.83
Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses. J Virol (1997) 0.83
Bovine parainfluenza type 3 virus infection: ultrastructural aspects of viral pathogenesis in the bovine respiratory tract. Infect Immun (1975) 0.83
Three viruses of the bovine respiratory disease complex apply different strategies to initiate infection. Vet Res (2014) 0.81
Cell injury with viruses. Am J Pathol (1975) 0.80
Role of cellular proteases in viral pathogenicity. Trans Am Clin Climatol Assoc (1979) 0.79
Potentiation by viral respiratory infection of ovalbumin-induced guinea-pig tracheal hyperresponsiveness: role for tachykinins. Br J Pharmacol (1995) 0.78
Immunity against parainfluenza-3 virus in cattle: anti-neuraminidase activity in serum and nasal secretion. Infect Immun (1973) 0.78
Thermal inactivation of Newcastle disease virus. I. Coupled inactivation rates of hemagglutinating and neuraminidase activities. J Virol (1973) 0.77
Membrane proteins and virus virulence. Trans Am Clin Climatol Assoc (1984) 0.76
Analysis of immunoprecipitated surface glycoproteins in measles virions and in membranes of infected cells. J Virol (1978) 0.75
Infective and noninfective hemagglutinating particles of Newcastle disease virus: biological and chemical characterization. J Virol (1975) 0.75
Investigation into alternative testing methodologies for characterization of influenza virus vaccine. Hum Vaccin Immunother (2015) 0.75
Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology (1975) 6.90
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis (1980) 4.61
Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity. Virology (1969) 4.45
Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology (1977) 4.33
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21
An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology (1966) 4.03
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
The membrane structure of lipid-containing viruses. Biochim Biophys Acta (1974) 3.92
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol (1995) 3.82
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology (1979) 3.80
On the role of the response of the cell membrane in determining virus virulence. Contrasting effects of the parainfluenza virus SV5 in two cell types. J Exp Med (1966) 3.71
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol (1976) 3.61
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology (1980) 3.53
Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol (1973) 3.49
The role of cytoplasmic membranes in poliovirus biosynthesis. Virology (1970) 3.46
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol (1992) 3.20
Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci U S A (1991) 3.18
Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13
Structure of the ribonucleoprotein of influenza virus. J Virol (1972) 3.11
A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08
Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J (1986) 3.00
Assembly of animal viruses at cellular membranes. Annu Rev Microbiol (1988) 2.99
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol (1996) 2.63
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A (1979) 2.58
Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell (1983) 2.54
On the role of microtubules in movement and alignment of nuclei in virus-induced syncytia. J Cell Biol (1968) 2.53
Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J (2001) 2.51
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology (1977) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5. Proc Natl Acad Sci U S A (1967) 2.46
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology (1998) 2.43
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J Virol (1992) 2.36
Location of the glycoprotein in the membrane of Sindbis virus. Nat New Biol (1971) 2.35
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Action of guanidine on the replication of poliovirus RNA. Virology (1968) 2.31
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology (1993) 2.23
Membranous structures associated with translation and transcription of poliovirus RNA. Science (1969) 2.21
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology (1979) 2.20
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
Horizontal transmission of HIV infection between two siblings. Lancet (1986) 2.17
A comparison of the polypeptides of four measles virus strains. Virology (1977) 2.15
Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins. Virology (1978) 2.13
Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol (2000) 2.11
Effect of arildone on modifications of poliovirus in vitro. Virology (1980) 2.10
Polarity of influenza and vesicular stomatitis virus maturation in MDCK cells: lack of a requirement for glycosylation of viral glycoproteins. Proc Natl Acad Sci U S A (1979) 2.09
Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region. J Biol Chem (1981) 2.04
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology (1973) 2.01
Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol (1994) 2.00
Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology (1983) 2.00
Cell-fusing activity of visna virus particles. Virology (1967) 1.98
Influenza virus proteins. II. Association with components of the cytoplasm. Virology (1973) 1.98
Action of dichlorobenzimidazole riboside on RNA synthesis in L-929 and HeLa cells. J Cell Biol (1976) 1.96
Characterization of poliovirus-specific structures associated with cytoplasmic membranes. Virology (1970) 1.95
Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology (1996) 1.95
Protease activation mutants of sendai virus. Activation of biological properties by specific proteases. Virology (1976) 1.95
Immunological studies of the functions of paramyxovirus glycoproteins. Virology (1981) 1.93
Basolateral maturation of retroviruses in polarized epithelial cells. J Virol (1983) 1.90
An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. Virology (1970) 1.88
Identification of the spike proteins of Rous sarcoma virus. Virology (1971) 1.87